Canopy Growth (CGC) Capital Expenditures (2019 - 2025)
Canopy Growth's (CGC) quarterly Capital Expenditures came in at $1.3 million in Q4 2025, up 48.49% year-on-year from $869756.7 in Q4 2024, and up 44.97% quarter-over-quarter from $890854.5 in Q3 2025.
Canopy Growth (CGC) Capital Expenditures (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Capital Expenditures across 7 years of filings, most recently posting $1.3 million for Q4 2025.
- Capital Expenditures for Q4 2025 came in at $1.3 million, up 48.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.3 million (down 9.3% YoY), and the FY2025 annual result was $7.5 million, up 194.42% from the prior year.
- Capital Expenditures came in at $1.3 million for Q4 2025 at Canopy Growth, up from $890854.5 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $21.0 million in Q1 2021 to a low of $50526.4 in Q1 2022.
- The 5-year median for Capital Expenditures is $1.4 million (2022), against an average of $3.5 million.
- Across the five-year window, Capital Expenditures sank 99.76% in 2022 and surged 4201.17% in 2023, its largest moves.
- Canopy Growth's Capital Expenditures stood at $763189.3 in 2021, then surged by 80.32% to $1.4 million in 2022, then slumped by 69.9% to $414278.0 in 2023, then jumped by 109.95% to $869756.7 in 2024, then jumped by 48.49% to $1.3 million in 2025.
- The last three Capital Expenditures figures came in at $1.3 million (Q4 2025), $890854.5 (Q3 2025), and $942556.5 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 890,854.51 |
| Sep 30, 2025 | 890,854.51 |
| Jun 30, 2025 | 942,556.52 |
| Jun 30, 2025 | 942,556.52 |
| Mar 31, 2025 | 2.15 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 869,756.71 |
| Dec 31, 2024 | 869,756.71 |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 184,786.19 |
| Mar 31, 2024 | 184,786.19 |
| Dec 31, 2023 | 414,278.04 |
| Dec 31, 2023 | 414,278.04 |
| Sep 30, 2023 | 514,692.02 |
| Sep 30, 2023 | 514,692.02 |